+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Provigil"

Cognitive and Memory Enhancer Drugs Market 2025-2033 - Product Thumbnail Image

Cognitive and Memory Enhancer Drugs Market 2025-2033

  • Report
  • March 2025
  • 139 Pages
  • Global
From
Hypersomnia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hypersomnia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Provigil is a prescription medication used to treat excessive sleepiness caused by certain medical conditions, such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is a central nervous system (CNS) stimulant drug, classified as a Schedule IV controlled substance by the U.S. Drug Enforcement Administration. Provigil is approved by the U.S. Food and Drug Administration (FDA) for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Provigil is part of the larger CNS drug market, which includes drugs used to treat a variety of neurological and psychiatric conditions. These drugs are used to treat conditions such as depression, anxiety, insomnia, and attention deficit hyperactivity disorder (ADHD). Some of the companies in the Provigil market include Cephalon, Inc., Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more